These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7583902)

  • 1. [Fatal hepatic necrosis during treatment with sodium valproate].
    Miguil M; Chlihi A; Mjahed K; Sarf I; Moutawakkil S; Benaguida M
    Cah Anesthesiol; 1995; 43(3):325-6. PubMed ID: 7583902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fatal hepatic failure in a normally developed 5-year-old boy caused by VPA monotherapy].
    König S; Scheffner D; Rauterberg-Ruland I; Kochen W; Hofmann WJ; Wokittel E; Schick U
    Monatsschr Kinderheilkd; 1987 Jun; 135(6):310-3. PubMed ID: 3112563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal fulminant hepatic failure due to sodium valproate in an adolescent.
    Puri AS; Sharma BC; Khan EM; Saraswat VA
    Indian Pediatr; 1994 Feb; 31(2):207-10. PubMed ID: 7875849
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatic encephalopathy precipitated by sodium valproate therapy.
    Subhash HS; Heddle RJ; Schultz DW; Ring J; Thompson CH
    Med J Aust; 2008 May; 188(9):549. PubMed ID: 18459937
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute fatal liver insufficiency due to valproic acid therapy].
    Binek J; Hany A; Egloff B; Heer M
    Schweiz Med Wochenschr; 1991 Feb; 121(7):228-33. PubMed ID: 2008603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: review of valproate hepatotoxicity in adults.
    König SA; Schenk M; Sick C; Holm E; Heubner C; Weiss A; König I; Hehlmann R
    Epilepsia; 1999 Jul; 40(7):1036-40. PubMed ID: 10403231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of valproic acid-associated hepatic failure with orthotopic liver transplantation.
    Bell EA; Shaefer MS; Markin RS; Wood RP; Langnas AN; Stratta RJ; Shaw BW
    Ann Pharmacother; 1992 Jan; 26(1):18-21. PubMed ID: 1606338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproate treatment after liver transplant in a patient with Lennox-Gastaut syndrome.
    Velizarova R; Gelisse P; Pageaux GP; Genton P; Crespel A
    Seizure; 2011 Jul; 20(6):500-1. PubMed ID: 21376637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid hepatic fatalities. III. U.S. experience since 1986.
    Bryant AE; Dreifuss FE
    Neurology; 1996 Feb; 46(2):465-9. PubMed ID: 8614514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
    Lackmann GM
    Pharmacology; 2004 Feb; 70(2):57-8. PubMed ID: 14685007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemorrhagic shock and fulminant hepatic failure associated with valproate].
    Fernandez-Fernandez FJ; Garcia-Rego J; Garcia-Jimenez A; Sesma P
    An Med Interna; 1995 Dec; 12(12):606-8. PubMed ID: 8679806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Valproate-associated hepatotoxicity--pathogenesis, clinical aspects, therapy and prevention].
    Siemes H; Nau H
    Klin Padiatr; 1991; 203(6):411-9. PubMed ID: 1758143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid-induced encephalopathy in very long course treated patients.
    Rousseau MC; Montana M; Villano P; Catala A; Blaya J; Valkov M; Allouard Y; Bugni E
    Brain Inj; 2009 Nov; 23(12):981-4. PubMed ID: 19831495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal hepatocerebral syndrome in siblings discordant for exposure to valproate.
    Lenn NJ; Ellis WG; Washburn ER; Ruebner B
    Epilepsia; 1990; 31(5):578-83. PubMed ID: 2119302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal liver failure in 16 children with valproate therapy.
    Scheffner D; König S; Rauterberg-Ruland I; Kochen W; Hofmann WJ; Unkelbach S
    Epilepsia; 1988; 29(5):530-42. PubMed ID: 3137017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A suspected case of late-onset sodium-valproate-induced hepatic failure.
    van Egmond H; Degomme P; de Simpel H; Dierick AM; Roels H
    Neuropediatrics; 1987 May; 18(2):96-8. PubMed ID: 3110642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperammonemic encephalopathy associated with valproate acid].
    Osuna MT; Burcet J; Ramió L; Ustrell X; Silva Y; Molins A
    Neurologia; 2003; 18(6):347-50. PubMed ID: 12838456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate-associated carnitine deficiency and malignant cerebral edema in the absence of hepatic failure.
    Triggs WJ; Gilmore RL; Millington DS; Cibula J; Bunch TS; Harman E
    Int J Clin Pharmacol Ther; 1997 Sep; 35(9):353-6. PubMed ID: 9314085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate induced hyperammonemic encephalopathy successfully treated with levocarnitine.
    Rigamonti A; Lauria G; Grimod G; Bianchi G; Salmaggi A
    J Clin Neurosci; 2014 Apr; 21(4):690-1. PubMed ID: 24119342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproate hepatotoxicity: a review and report of two instances in adults.
    Dickinson RG; Bassett ML; Searle J; Tyrer JH; Eadie MJ
    Clin Exp Neurol; 1985; 21():79-91. PubMed ID: 3939614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.